Dr. Galsky discusses combo of nivolumab plus trastuzumab deruxtecan in urothelial carcinoma

Immunotherapy Drug Can Lower Recurrence When Bladder Cancer Spreads

Immunotherapy After Bladder Cancer Surgery Shows Excellent Cancer-free Survival Rates

"Biology and Genomic Distinctions in Metastatic Urothelial Carcinoma and Upper Tract Urothelial Cancers "

"Subset Of Cells In Bladder Cancer May Hinder Immunotherapy Outcomes" - Kristie L. Kahl

Discovery Could Lead to Higher Response Rates for Bladder Cancer Patients Treated with Immunotherapy

"Dr. Galsky On Neoadjuvant Immune Checkpoint Blockade In Bladder Cancer"

"Two Large Trials Investigate Combination Immunotherapy In Bladder Cancer" - Brielle Urciuoli

"Dr. Galsky Discusses Ongoing Combination Immunotherapy Trials In Bladder Cancer" - Angelica Welch

"Mount Sinai Study Identifies Potential New Treatment Target For Aggressive Bladder Cancer"

"Dr. Galsky Discusses Combination Immunotherapy In Bladder Cancer"